RESULTS: The continent rate of 2, 4, 8 weeks postoperatively were 81.0%, 89.7%, and 96.6%, respectively. Univariate obtained differences in Age, PV, MUL, and IPLL after 2 weeks of the operation. Multivariate analysis showed Age (P[0.001), MUL (P[ 0.001) and IPLL (P[ 0.012) were the independence factors for the recovery of continence of 2 weeks after surgery. Univariate obtained differences in PV, MUL, and IPLL after 4 weeks of the operation . Multivariate analysis showed Age (P[0.001) and MUL (P[ 0.013) were the independence factors for the recovery of continence of 4 weeks after surgery. No significant association except age (P[0.012) was found between MRI factors to the recovery of continence of 8 weeks after surgery.
INTRODUCTION AND OBJECTIVES:
Patients with prostate cancer (PC) who wish to pursue active surveillance (AS) present a unique challenge to the urologist if these men have lower urinary tract symptoms (LUTS) or urinary retention. The objective of this study was to describe clinical and pathologic outcomes for patients on AS for PC who also underwent holmium laser enucleation of the prostate (HoLEP) for LUTS or urinary retention.
METHODS: Through an IRB-approved protocol, we prospectively collect preoperative, perioperative, and postoperative data on all patients undergoing HoLEP at our institution. We queried this database to include all men with a known diagnosis of PC who chose active surveillance as primary treatment for their malignancy. We excluded men who were planning to undergo radiation as primary cancer treatment following debulking HoLEP due to obstructive LUTS. Perioperative and postoperative patient characteristics were evaluated. RESULTS: We included 71 patients for analysis (Table 1 ). The median patient age was 74 years, and 38% of patients required an indwelling catheter or intermittent catheterization for urinary retention before surgery. Preoperatively, the majority of patients had Gleason sum 6 PC and the median PSA for the group was 9.0 ng/mL (IQR 5.9-13.6). The median weight of tissue removed was 73 grams (IQR 37-101). Most patients (63.4%) had no malignancy on HoLEP pathology, and the three patients with preoperative Gleason 7 and 8 had either Gleason 6 or no cancer on HoLEP pathology. Over a median 12-month follow-up period, all patients were free of urinary retention, and 90.1% of patients remained on AS without plans for other therapy. Median AUA symptom scores were significantly lower postoperatively compared to preoperatively (6 vs 22, respectively; p<0.01). Additionally, the PSA decreased to a median of 1.4 ng/mL (IQR 0.7-3.5).
CONCLUSIONS: In patients with LUTS or urinary retention wishing to undergo AS for PC, HoLEP will provide many men significant symptomatic improvement and relief of urinary retention while allowing them to continue this treatment option.
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PD10-06 COMPARISON OF INCIDENTAL PROSTATE CANCER DETECTION BETWEEN HOLEP AND BIPOLAR TURP
Wen Dong*, Chun Jiang, Weibin Xie, Jian Huang, Hao Huang, Xinxiang Fan, Guangzhou, China, People's Republic of INTRODUCTION AND OBJECTIVES: Holmium laser enucleation of the prostate (HoLEP) has become a popular alternative to TURP for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostate hyperplasia (BPH). Previous studies indicated that HoLEP may have a higher rate of incidental prostate cancer (iPCa) detection because of a more efficient tissue removed during surgery. However, some other studies reported it's identical for both procedures. In this study, we aim to evaluate whether the surgical procedure itself (HoLEP vs. TURP) influences iPCa detection by analysis of a large cohort of patients.
METHODS: 602 patients undergoing HoLEP (n [ 292) or TURP (n [ 312) were retrospectively analyzed for total PSA, prostate volume, PSA density, history of prostate biopsy, resected prostate weight, and histopathological features. IPSS, Qmax, PVR were also collected before and after surgery. Parameters were analyzed by Fisher's exact test and T test or Mann-Whitney U test for dichotomous and continuous variables, respectively. Univariate and multivariate logistic regression removed used to identify independent predictors of incidental PCa (iPCa).
RESULTS: Median patient age was 66 and 65 years in the HoLEP and bTURP group, respectively. Median preoperative total PSA was 3.7 ng/ml for HoLEP and 3.3 ng/ml for bTURP patients (p[0.08). Median preoperative prostate volume was 64.0 cc for HoLEP and 58.0 cc for bTURP (p[0.02). Mean percentage of tissue removed by HoLEP and bTURP was 69.5% and 51.2% (p < 0.001), respectively. IPCa was found in 12.3% of HoLEP specimens compared to 6.1% in bTURP (p [ 0.01). There were no differences for IPSS and PVR reduction, Qmax increase for each procedure. In multivariate logistic regression, we identified the choice of procedure (OR 1.46; 95% CI 1.24e1.65, p [ 0.04) and PSA density (OR 2.13; 95% CI 1.09e4.18, p [ 0.028) as independent predictors for the detection of iPCa.
CONCLUSIONS: In this study, HoLEP provides a significantly higher iPCa detection than bTURP although most of them were removed cancer.). might be a result of a more efficient tissue removal during HoLEP. HoLEP had similar effect for resolution of LUTS as bTURP.
